Literature DB >> 21860038

Psychopharmacology of aggression in schizophrenia.

Peter Buckley1, Leslie Citrome, Carmen Nichita, Michael Vitacco.   

Abstract

The management of aggression in patients with schizophrenia is a complex and challenging clinical dilemma. It also is greatly influenced by prevailing societal and medicolegal considerations regarding the perceived associations between violence and mental illness. This article provides a succinct account of a complex area and offers evidence for available treatments to reduce the occurrence of violent behavior among patients with schizophrenia.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21860038      PMCID： PMC3160216          DOI： 10.1093/schbul/sbr104

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


  35 in total

1.  Regaining mental capacity for treatment decisions following psychiatric admission: a clinico-ethical study.

Authors:  G S Owen; I Chis Ster; A S David; G Szmukler; P Hayward; G Richardson; M Hotopf
Journal:  Psychol Med       Date:  2010-03-29       Impact factor: 7.723

2.  Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.

Authors:  Wen-Yu Hsu; Si-Sheng Huang; Bo-Shyan Lee; Nan-Ying Chiu
Journal:  J Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.153

Review 3.  Pathways to aggression in schizophrenia affect results of treatment.

Authors:  Jan Volavka; Leslie Citrome
Journal:  Schizophr Bull       Date:  2011-05-11       Impact factor: 9.306

4.  Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients.

Authors:  Michael P Wilson; Kai MacDonald; Gary M Vilke; David Feifel
Journal:  J Emerg Med       Date:  2010-06-12       Impact factor: 1.484

5.  Informed consent to research in persons with schizophrenia spectrum disorders.

Authors:  Lora Humphrey Beebe; Kathlene Smith
Journal:  Nurs Ethics       Date:  2010-07       Impact factor: 2.874

Review 6.  Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.

Authors:  L Citrome
Journal:  Int J Clin Pract       Date:  2010-12-29       Impact factor: 2.503

7.  Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.

Authors:  Stephen R Marder; Sebastian Sorsaburu; Eduardo Dunayevich; Jamie L Karagianis; Ian C Dawe; Deborah M Falk; Mary Anne Dellva; Janice L Carlson; Patrizia A Cavazzoni; Robert W Baker
Journal:  J Clin Psychiatry       Date:  2010-02-09       Impact factor: 4.384

8.  Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.

Authors:  Michael H Allen; Martin Debanné; Coralie Lazignac; Eric Adam; L Miriam Dickinson; Cristian Damsa
Journal:  Am J Psychiatry       Date:  2011-01-18       Impact factor: 18.112

9.  Assessing risk of future violence among forensic psychiatric inpatients with the Classification of Violence Risk (COVR).

Authors:  Robert J Snowden; Nicola S Gray; John Taylor; Suzanne Fitzgerald
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

10.  Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study.

Authors:  Hikaru Hori; Nobuhisa Ueda; Reiji Yoshimura; Hiroshi Yamamoto; Kenta Wani; Yoshinori Etoh; Kensuke Haraga; Junichi Kitahara; Jun Nakamura
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132
View more
  7 in total

1.  Aggression in schizophrenia.

Authors:  Mark R Serper
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

2.  Violence and schizophrenia.

Authors:  Heidi J Wehring; William T Carpenter
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

Review 3.  Guidelines for the Pharmacotherapy of Schizophrenia in Adults.

Authors:  Gary Remington; Donald Addington; William Honer; Zahinoor Ismail; Thomas Raedler; Michael Teehan
Journal:  Can J Psychiatry       Date:  2017-07-13       Impact factor: 4.356

Review 4.  Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies.

Authors:  Katrina Witt; Richard van Dorn; Seena Fazel
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 5.  A Research Agenda for the Assessment and Management of Acute Behavioral Changes in Elderly Emergency Department Patients.

Authors:  Christina Shenvi; Michael P Wilson; Alessandra Aldai; David Pepper; Michael Gerardi
Journal:  West J Emerg Med       Date:  2019-02-19

6.  Biological Aspects of Aggression and Violence in Schizophrenia.

Authors:  WonKyung Cho; Won-Suk Shin; Iseul An; Minji Bang; Doo-Yeoun Cho; Sang-Hyuk Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-11-20       Impact factor: 2.582

7.  Caregivers' Experiences of Aggressive Persons with Schizophrenia.

Authors:  Sailaxmi Gandhi
Journal:  Indian J Psychol Med       Date:  2020-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.